Life value

STELLAPHARM was born to care and protect patient’s health, to help enhancing their lives and living longer. Your health, for today and for future.

PHARMACEUTICAL INDUSTRY STRIVES TO PRODUCE NEW DRUG FORMS

Vietnam is focusing on improving research capacity and application of new drug production technology, promoting clinical pharmacy development and strengthening supervision of safe and reasonable drug use. Vietnam is focusing on improving research capacity and application of new drug production technology, promoting clinical pharmacy development and strengthening supervision of safe and reasonable drug use, aiming

TOP 10 REPUTABLE PHARMACEUTICAL COMPANIES IN 2023

On November 28, 2023, Vietnam Evaluation Report Joint Stock Company (Vietnam Report) officially announced the Top 10 prestigious Pharmaceutical Companies in 2023. Top 10 reputable Pharmaceutical Companies are built on scientific and objective principles. Companies are evaluated and ranked based on 3 main criteria: (1) Financial capacity shown on the most recent year’s financial statements;

A FOCUS ON THE IMPROVEMENT OF PEOPLE’S LIVES BY PROVIDING EFFECTIVE AND AFFORDABLE TREATMENTS.

By Mr. Ong Van Dung, General Director, Stellapharm Stellapharm (former name was STADA-VN – a Joint Venture Pharmaceutical Company formed in 2002 with a Vietnamesecompany named M.S.T and German cooperation named STADA Arzneimittel). Stellapharm has become one of the leading generic pharmaceutical manufacturers in Vietnam, we follow the global quality standard in accordance with European

PHARMACEUTICAL COMPANIES URGED TO INVEST IN R&D, IMPROVE COMPETITIVENESS

It is critical for pharmaceutical companies to improve competitiveness with a focus on research and development (R&D), production technology and digitalisation. According to experts, this will help them expand their shares in the domestic market which remains being dominated by imported drugs and extend their international reach.Vietnam’s pharmaceutical market has significant potential. The Ministry of

OVERVIEW OF VIETNAM’S PHARMACEUTICAL MANUFACTURING INDUSTRY 2023. WHAT DIRECTION FOR PHARMACEUTICAL ENTERPRISES?

Despite having a good market, the pharmaceutical manufacturing in Vietnam still faces many difficulties. This difficulty comes from industry competition, world competition and technological development. In order for the pharmaceutical manufacturing to develop, what should pharmaceutical enterprises do? Overview of Vietnam’s pharmaceutical manufacturing industry 2023.The market for the pharmaceutical industry in Vietnam is relatively active:The

THROUGH THE MPP ORGANIZATION, STELLAPHARM GETS THE 3rd APPROVAL TO PRODUCE SHIONOGI'S COVID-19 ORAL PILL

As one of seven generic drug manufacturers selected by MPP and becoming a sub-licensee of Shionogi – a Japanese pharmaceutical manufacturer to produce of XOCOVA™ drug, generic version. Stellapharm is honored and proud to have contributed to repelling the COVID-19 pandemic with drugs. This is the third oral product in the world to be recognized

Prediabetes: 7 steps to take now

What is prediabetes? Prediabetes is a serious health condition where blood sugar levels are higher than normal, but not high enough yet to be diagnosed as type 2 diabetes. Approximately 96 million American adults – more than 1 in 3 – have prediabetes. Of those with prediabetes, more than 80% don’t know they have it.

Launching Hepatitis C Product "Lesovir" in Vietnam

Lesovir is manufactured by its EU-GMP facility and distributed via exclusive distributor, Khuong Duy Pharma Co., Ltd.

THROUGH THE MPP ORGANIZATION, STELLAPHARM GETS THE APPROVAL TO PRODUCE PFIZER’S ANTI-COVID-19 PILL

On February 21, 2022, Stellapharm officially signed a contract with MPP (Medicines Patent Pool), a UNITED NATIONS-backed public health organization to become the only manufacturer in Vietnam allowed to produce a generic version of Pfizer’s oral COVID-19 treatment, nirmatrelvir, which will be co-packaged with ritonavir, under the voluntary licensing agreement between Pfizer and the MPP.

Drug Administration grants licences for first three made-in-Việt Nam Molnupiravir products

HÀ NỘI — The Drug Administration of Việt Nam under the Ministry of Health has issued the list of three COVID-19 treatment drugs produced in Việt Nam that contain the antiviral ingredient Molnupiravir, which have been granted certificates of registration for conditional use. The three products – Molravir 400mg produced by Boston Việt Nam Pharma (based in

First oral antiviral for COVID-19, Lagevrio (molnupiravir), approved by MHRA

The antiviral was found to be safe and effective following a stringent review of the available evidence. The antiviral Lagevrio (molnupiravir) is safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19 who are at increased risk of developing severe disease, the Medicines and Healthcare products Regulatory

27 generic manufacturers sign agreements with MPP to produce low-cost versions of COVID-19 antiviral medication molnupiravir for supply in 105 low- and-middle-income countries

20 January 2022 Geneva – The Medicines Patent Pool (MPP) announced today that it has signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicence agreements are the result of the voluntary licensing agreement signed by MPP and

Stellapharm supports European partners in Covid-19 pandemic

Since the beginning of February this year, many consignments of Stella's pharmaceutical products with a total of nearly 200 million units have been urgently exported by air to markets in Germany, France, Austria, Belgium, Ireland, etc.

Medical myths: All about allergies

In brief, an allergy is an unusual or exaggerated immune response triggered by a particular substance. Symptoms often include itchy eyes, wheezing, and sneezing. For many people, allergic reactions are uncomfortable and unpleasant, but they can be life-threatening for others. According to estimates from the Centers for Disease Control and Prevention (CDC), up to 60

Molnupiravir – an oral antiviral treatment for COVID-19

A novel coronavirus, originally identified in Wuhan City, China, was reported to the World Health Organization on 31 December 2019, and the associated disease has subsequently become a worldwide pandemic. An effective antiviral therapeutic has since been intensively sought. Coronaviruses use an RNA-dependent RNA polymerase (RdRp) for the replication and transcription of their RNA genome.

THROUGH THE MPP ORGANIZATION, STELLAPHARM GETS THE APPROVAL FROM MSD TO PRODUCE MOLNUPIRAVIR IN VIETNAM

On January 10, 2022, Stellapharm officially signed an agreement with MPP (Medicines Patent Pool), a UNITED NATIONS-backed public health organization to become the only manufacturer in Vietnam allowed to produce the COVID-19 treatment molnupiravir under the "Voluntary Licensing" program for MSD, a trade name of Merck & Co., Inc., Kenilworth, NJ, USA.

Groundbreaking Ceremony for Hormone - Steroid - Ointment Factory complying with EU-GMP and PIC/S

This will be the first steroid-hormone pharmaceutical factory in Vietnam and among a few ASEAN factories built in compliance with European Standards for this line of products.

EU-GMP Inspection, 2019

“Accrediting the fifth EU-GMP is one of our commitment on maintaining highest EU standards and quality of products with affordable prices” said by Choo Yan Ho, the Chairman.

EU-GMP Inspection, 2016

On 15 March 2016, the fourth EU-GMP Inspection was conducted at STADA – VN J.V. Co., Ltd., Binh Duong Branch, currently known as STELLAPHARM J.V. Co., Ltd. – Branch 1

An oral pill for COVID-19? Molnupiravir shows promise

[Updated to July 2021] The results of the trial demonstrate the safety, tolerability, and antiviral efficacy of molnupiravir to reduce replication of SARS-CoV-2 and accelerate clearance of infectious virus and support ongoing trials of molnupiravir to prevent progression of COVID-19 and eliminate onward transmission of SARS-CoV-2. After more than one year into the coronavirus disease

Japan GMP Accreditation, 2015

On 06 January 2015, STADA – VN J.V. Co., Ltd., Binh Duong Branch (the “STELLA” or “Factory II“), was appreciated by Ministry of Health, Labour and Welfare (the "MHLW") issued the certificate of Japan GMP for the product of Soleton 80 with its composition and strength: Zaltoprofen 80 mg

Company Name Change

STADA - VN JOINT VENTURE CO., LTD. officially changed its name to STELLAPHARM J.V. CO., LTD. since 16 August 2019.

EU-GMP Inspection, 2013

On 19 March 2013, the third EU-GMP Inspection was conducted in five continuous days at STADA – VN J.V. Co., Ltd., Binh Duong Branch (the “Company” or “Factory II“), located at Vietnam – Singapore Industrial Park, Binh Duong and the Factory II was recognized as a pharma facility complying with European Good Manufacturing Practice issued

Exercising later in the day may reduce insulin resistance, control blood sugar

According to the World Health Organization, obesity rates have tripled worldwide since 1975. The connection between obesity and insulin resistance is bidirectional. Insulin resistance often develops due to being overweight or obese, which can lead to type 2 diabetes. Since type 2 diabetes can be a costly disease to treat, contribute to many health issues,

FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults

in December 23, 2021, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Merck’s molnupiravir for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death, and for whom

Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?

By Stephanie NolenOct. 17, 2021 Merck has taken a step to make its antiviral pill available in poor nations, but many obstacles remain for broad access to coronavirus drugs. Nearly a year after the first Covid-19 vaccination campaigns began, the vast majority of the shots have gone to people in wealthy nations, with no clear

We produce a wide
range of prescription
and non-prescription drugs

Parastad Kid

Paracetamol is an effective alternative to aspirin as an analgesic-antipyretic agent; however, it is not a useful agent to treat inflammatory conditions. Paracetamol lowers body temperature in patients with fever but rarely lowers normal body temperature.

Partamol 500 CAP

Paracetamol is an effective alternative to aspirin as an analgesic-antipyretic agent; however, it is not a useful agent to treat inflammatory conditions. Paracetamol lowers body temperature in patients with fever but rarely lowers normal body temperature.

Partamol-Cafein

Partamol-Cafein is fixed-combination of paracetamol and caffeine that is indicated for treatment of most painful and febrile conditions, for example, headache, including migraine, backache, toothache.....

Castella 90

Castella 90 is co-administered with acetylsalicylic in the prevention of atherothrombotic events in adult patients with acute coronary syndromes and with history of myocardial infarction and a high risk of developing an atherothrombotic event.

Ezecept 20/10

Ezecept 20/10 containing ezetimibe and atorvastatin, is a lipid-lowering agent that selectively inhibits the intestinal absorption of cholesterol and related phytosterols and inhibits endogenous cholesterol synthesis.

Amioxilto 200

Amiodarone is an antiarrhythmic drug used to treat and prevent certain types of arrhythmias. These arrhythmias include ventricular tachycardia, ventricular fibrillation, and wide QRS tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia. However, evidence in cardiac arrest is limited.

Diosmin 500

Diosmin 500 is used in treatment of symptoms related to venolymphatic insufficiency and functional symptoms related to acute hemorrhoidal attack.

Keamine

Keamine helps to prevention and therapy of damages due to faulty or deficient protein metabolism in chronic renal insufficiency.

Xelostad 10

Xelostad 10 is used for prevention of venous thromboembolism (VTE) in adult patients, treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.

Eperistad

Eperistad is effective in improving myotonic symptoms such as stiffness of shoulders, cervical pain, muscle contraction type headache, dizziness, lower back pain and rigidity of extremeties which may accompany encephalomyelopathies, cervical syndrome, periarthritis of the shoulder or lumbago.

Helix STELLA

Helix STELLA containing dried ivy leaf extract helps relieve cough and reduce phlegm.

Molnupiravir STELLA 400 mg

Molnupiravir is indicated for the treatment of mild to moderate COVID-19 disease in adults with a positive diagnostic test for SARS-CoV-2 and with at least one risk factor for severe disease progression.

Flustad 75

Flustad 75 is an antiviral drug for systemic use indicated for treatment and prevention of influenza in adults and children (including full term neonates) following contact with an infected person influenza. Flustad 75 is not a substitute for influenza vaccination.

Lesovir

Lesovir is a fixed-dose combination of ledipasvir and sofosbuvir which are direct-acting antiviral agents against the hepatitis C virus.

Stadfovir 25

Stadfovir 25 is indicated for the treatment of chronic hepatitis B in adults and adolescents.

Tefostad T300

Tefostad T300 is used in conjunction with other antiretroviral agents (should not be used alone) in the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults, post-exposure prophylaxis of HIV infection and in treatment of chronic hepatitis B in adults.

Efatrio

Efatrio is indicated for the treatment of HIV-1 infection in adults and adolescents (from 12 years of age and weighing ≥ 40 kg).

Bicimax

Bicimax is used for supplementation of deficiencies of the vitamins B complex, vitamin C, calcium and magnesium: e.g., prolonged stress, prolonged infection and fever, intestinal diseases, gastrectomy, alcohol abuse, ...

Pravitce

Pravitce contains calcium and vitamin C. Its main use is to supplement these two substances for people suffering from nutritional deficiencies, during pregnancy, lactation, adolescents during growth, and the elderly.

Calcium STELLA 500 mg

Calcium STELLA 500 mg is used for prevention and treatment of calcium deficiency.

Elnitine

Elnitine is used for supplementation of calcium and magnesium in for patients in convalescence, stress, elderly patients, menopausal women, children in growth.

Predstad 20

Treatment and/or suppression of inflammatory and allergic disorders.

Bamstad

Bamstad is indicated for management of asthma, bronchospasm and/or reversible airways obstruction in adults.

Gliptinestad 50

Gliptinestad (Sitagliptin 50 mg) is indicated to improve glycaemic control in adult patients with type 2 diabetes mellitus.

Mopristad 5

Mopristad 5 is indicated for the treatment of gastrointestinal symptoms (heartburn, nausea/vomiting) associated with functional dyspepsia (chronic gastritis).

Zecein 80

Zecein 80 belongs to the group of smooth muscle spasmolytic agent indicated for treatment of pain syndromes of various organs: gastrointestinal, biliary, urogenital and vascular systems.

Alumastad

Alumastad contains dried aluminum hydroxide gel and magnesium hydroxide which are antacids pain reliever and indigestion discomfort by neutralizing acid, reducing the excess acidity in the stomach.

Odistad 120

Odistad 120 is used for conjunction with a mildly hypocaloric diet for the treatment of obese patients (BMI ≥ 30 kg/m²) or overweight patients (BMI ≥ 28 kg/m²) with associated risk factors (hypertension, diabetes mellitus, hyperlipidemia).

Shaping Tomorrow

We are embracing technology and partnership to leverage that strengthen to advance research, develop and produce new generic drugs.